Benefit for Women’s INOCA Eludes Familar Cardiovascular Meds in WARRIOR

(MedPage Today) — CHICAGO — The WARRIOR trial was not able to prove that intensive medical therapy reduced major adverse cardiovascular events (MACE) in women with ischemia but no obstructive disease.
For symptomatic patients with suspected…